Peter Sandercock, Steff Lewis. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Fibrinolytic Agents/administration & dosageFibrinolytic Agents/therapeutic useHumansInjections, Intra-ArterialSex CharacteristicsStroke/drug therapyTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/therapeutic useTreatment Outcome
Substances: See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 2006 PMID: 16888265 DOI: 10.1161/01.STR.0000237086.85164.92
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914